N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide
C27H36N4O3 — CID 42171259
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide
N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide (PubChem CID 42171259) has the molecular formula C27H36N4O3 and a molecular weight of 464.61 g/mol. Its IUPAC name is N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 42171259 |
| Molecular Formula | C27H36N4O3 |
| Molecular Weight | 464.61 g/mol |
| Exact Mass | 464.28 |
| IUPAC Name | N-cyclopentyl-1-(3-methylbutyl)-4-oxo-5-[(2R)-2-pyridin-3-ylpiperidine-1-carbonyl]pyridine-3-carboxamide |
| SMILES | CC(C)CCn1cc(C(=O)NC2CCCC2)c(=O)c(C(=O)N2CCCC[C@@H]2c2cccnc2)c1 |
| InChI | InChI=1S/C27H36N4O3/c1-19(2)12-15-30-17-22(26(33)29-21-9-3-4-10-21)25(32)23(18-30)27(34)31-14-6-5-11-24(31)20-8-7-13-28-16-20/h7-8,13,16-19,21,24H,3-6,9-12,14-15H2,1-2H3,(H,29,33)/t24-/m1/s1 |
| InChIKey | PXOCWFGAJBUCMH-XMMPIXPASA-N |
| XLogP | 4.33 |
| TPSA | 84.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 464.61 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 42171259 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.